Related Experiment Video
Updated: Jun 10, 2025
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Identification of miR-6794-3p as a suppressor in pancreatic cancer metastasis
Ha Gyeong Kim1,2, Yunmi Cho2, Jae-Seon Lee2,3,4
1Department of Microbiology, College of Medicine, Inha University, Incheon 22212, Republic of Korea.
Abstract:
Metastasis is a major cause of treatment failure in patients with pancreatic cancer, highlighting the urgent need for effective therapeutic strategies. Here, we focused on identifying novel miRNAs with key roles in metastasis of pancreatic cancer. Microarray analysis of miRNA expression in metastatic and non-metastatic pancreatic cancer samples revealed significantly lower expression of miR-6794-3p in the metastatic tumor group. Gain- and loss-of-function approaches using the pancreatic cancer cell lines MIA-PaCa-2 and HPAF-II expressing low and high levels of miR-6794-3p, respectively, indicated a role of miR-6794-3p in suppression of cell invasion, migration, and EMT signaling. Importantly, our results showed that miR-6794-3p exerts its effects by inhibiting expression of the chromatin remodeling factor, RBBP4. The resulting suppression of RBBP4 induced an increase in the levels of GRHL2 involved in regulating invasion, migration, and EMT signaling in metastatic pancreatic cancer cells. Consistent with these findings, low miR-6794-3p expression levels correlate with poor pancreatic cancer patient survival. Additional preclinical experiments on nude mice clearly demonstrated inhibitory effects of miR-6794-3p on pancreatic cancer cell metastasis. The collective results highlight the functional significance of miR-6794-3p as a suppressor of metastasis and support its predictive utility as a prognostic biomarker and therapeutic target in pancreatic cancer.
Insights
MicroRNA miR-6794-3p suppresses pancreatic cancer metastasis by inhibiting RBBP4 and GRHL2. Low miR-6794-3p levels predict poor survival, suggesting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic cancer metastasis is a primary driver of treatment failure.
- Identifying novel microRNAs (miRNAs) is crucial for developing effective anti-metastatic therapies.
- Understanding miRNA roles in pancreatic cancer progression is essential.
Purpose of the Study:
- To identify and characterize novel miRNAs involved in pancreatic cancer metastasis.
- To elucidate the molecular mechanisms underlying miR-6794-3p's function in metastasis.
- To evaluate miR-6794-3p as a potential prognostic biomarker and therapeutic target.
Main Methods:
- Microarray analysis of miRNA expression in metastatic versus non-metastatic pancreatic tumors.
- Gain- and loss-of-function studies in pancreatic cancer cell lines (MIA-PaCa-2, HPAF-II).
- Investigation of downstream targets including RBBP4 and GRHL2.
- Preclinical metastasis models in nude mice.
Main Results:
- miR-6794-3p expression was significantly lower in metastatic pancreatic tumors.
- miR-6794-3p suppressed cell invasion, migration, and epithelial-mesenchymal transition (EMT) signaling.
- miR-6794-3p inhibited RBBP4 expression, leading to increased GRHL2 levels.
- Low miR-6794-3p levels correlated with poor patient survival.
- In vivo studies confirmed miR-6794-3p's inhibitory effect on metastasis.
Conclusions:
- miR-6794-3p acts as a tumor suppressor by inhibiting pancreatic cancer metastasis.
- The miR-6794-3p/RBBP4/GRHL2 axis is a key regulator of pancreatic cancer invasion and migration.
- miR-6794-3p holds significant potential as a prognostic biomarker and therapeutic target for pancreatic cancer.
Related Concept Videos
01:22MicroRNAs
02:23Abnormal Proliferation
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...